Antiretroviral therapies associated with lipoatrophy in HIV-infected women
about
Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study.Assessment of ultrasound for use in detecting lipoatrophy in HIV-infected patients taking combination antiretroviral therapy.Severity of lipodystrophy is associated with decreased health-related quality of life.Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders.A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy.Appearance concerns and psychological distress among HIV-infected individuals with injection drug use histories: prospective analysesObesity Is Not Associated with Impaired Immune Response to Influenza Vaccination in HIV-Infected PersonsAssociation of regional body composition with bone mineral density in HIV-infected and HIV-uninfected women: women's interagency HIV study.Mitochondrial oxidative phosphorylation protein levels in peripheral blood mononuclear cells correlate with levels in subcutaneous adipose tissue within samples differing by HIV and lipoatrophy statusInvestigating the effects of metabolic dysregulation on hair follicles: a comparison of HIV-infected women with and without central lipohypertrophy.Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.Brief Report: Association of Adipokines With Bone Mineral Density in HIV-Infected and HIV-Uninfected Women.A prospective study of body fat redistribution, lipid, and glucose parameters in HIV-infected patients initiating combination antiretroviral therapy.
P2860
Q33705639-7F04E5A5-D9E2-42FD-9BBE-ED9D51616A81Q33797575-778004AC-1C57-4712-8B3B-25FB86EB4DC0Q34087789-BE51E302-897B-41D8-AE69-DD616C0DB7E1Q35762427-C4B23943-9843-4637-AD20-695CDBD27C32Q36184633-3936A119-4C79-4006-B7D2-C9CDFB98B516Q36184648-1EA22A15-7F77-46EC-B0FD-CFDEE5EA62F8Q36241275-9A253629-1BDA-43E4-A059-B9E02CB73D99Q36389108-0B99D75F-3821-4C2D-8AAC-280CB2AA8133Q37114196-DA01A7E1-2247-4F26-AF42-4707A6D27C69Q37203374-48E88F2E-821E-4D8C-BBE7-F124102720FAQ38687132-9B23CD91-2135-472E-9000-F9BAD9EC5762Q40477888-B94279F5-CBE7-4187-82FD-A52991E5585BQ46269347-1757145F-B597-4563-A0FA-3841CE85FC13
P2860
Antiretroviral therapies associated with lipoatrophy in HIV-infected women
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Antiretroviral therapies associated with lipoatrophy in HIV-infected women
@ast
Antiretroviral therapies associated with lipoatrophy in HIV-infected women
@en
type
label
Antiretroviral therapies associated with lipoatrophy in HIV-infected women
@ast
Antiretroviral therapies associated with lipoatrophy in HIV-infected women
@en
prefLabel
Antiretroviral therapies associated with lipoatrophy in HIV-infected women
@ast
Antiretroviral therapies associated with lipoatrophy in HIV-infected women
@en
P2093
P2860
P356
P1476
Antiretroviral therapies associated with lipoatrophy in HIV-infected women
@en
P2093
Andrea Kovacs
Charles Hyman
Jessica E Justman
Mardge H Cohen
Mary Young
Phyllis C Tien
Stephen R Cole
Yolanda Barrón
P2860
P304
P356
10.1089/APC.2006.128
P577
2007-05-01T00:00:00Z